ANI Pharmaceuticals
ANIP
#4819
Rank
โ‚ฌ1.57 B
Marketcap
70,23ย โ‚ฌ
Share price
-1.17%
Change (1 day)
30.50%
Change (1 year)

ANI Pharmaceuticals (ANIP) - Total debt

Total debt on the balance sheet as of September 2025 : โ‚ฌ0.53 Billion

According to ANI Pharmaceuticals's latest financial reports the company's total debt is โ‚ฌ0.53 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

ANI Pharmaceuticals - Total debt on balance sheet (from 2000 to 2025)

Total debt by year

Year Total debt Change
2024-12-31โ‚ฌ0.59 B132.08%
2023-12-31โ‚ฌ0.25 B-3.25%
2022-12-31โ‚ฌ0.26 B5.26%
2021-12-31โ‚ฌ0.25 B68.08%
2020-12-31โ‚ฌ0.15 B-8.95%
2019-12-31โ‚ฌ0.16 B3.65%
2018-12-31โ‚ฌ0.15 B-4.74%
2017-12-31โ‚ฌ0.16 B46.42%
2016-12-31โ‚ฌ0.11 B10.56%
2015-12-31โ‚ฌ0.10 B18.42%
2014-12-31โ‚ฌ87.6 M
2013-12-31N/A-100%
2012-12-31โ‚ฌ5.96 M-55.35%
2011-12-31โ‚ฌ13.34 M-4.26%
2010-12-31โ‚ฌ13.94 M19.8%
2009-12-31โ‚ฌ11.63 M
2000-12-31โ‚ฌ0.53 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Jazz Pharmaceuticals
JAZZ
โ‚ฌ4.66 B 775.13%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Evoke Pharma
EVOK
โ‚ฌ4.4 M-99.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ14.66 B 2,652.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Pfizer
PFE
โ‚ฌ52.26 B 9,709.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Lannett Company
LCI
โ‚ฌ0.54 B 3.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚ฌ2.25 M-99.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
โ‚ฌ7.75 B 1,356.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ27.50 B 5,062.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Royalty Pharma
RPRX
โ‚ฌ7.68 B 1,342.14%๐Ÿ‡ฌ๐Ÿ‡ง UK